Tableau de bord de la cohorte

La mission du GP2 est de mieux comprendre l’architecture génétique de la maladie de Parkinson (MP) par le génotypage de groupes de patients différents et l’étude des formes soulevant une forte suspicion de cause monogénique de la MP. En soutien à cette mission, nous constituons des cohortes différentes dans le monde en collaborant et en partageant ouvertement les données, les processus et les résultats. Le tableau de bord ci-dessous présente les étapes que nous avons franchies jusqu’à présent. Consultez régulièrement cette page car les données sont mises à jour sur une base trimestrielle.

Total des données mondiales

0
Emplacements uniques
0
Cohortes
0
Echantillons prévus
0
Echantillons terminés

Last Updated: August 10, 2022 | Original design by GP2 Hackathon 2021 Team: Mary Makarious, Kajsa Brolin, Yeajin Song, and Anastasia Illarionova.

Showing 10 of 238 cohort studies.

GP2 - Bangladesh

National Institutes of Neuroscience & Hospital, Dhaka, Bangladesh | Dhaka, Bangladesh
Number of Samples Completed and Expected
Case Samples
Case Samples

Pending
Non-PD Samples
Non-PD Samples

Pending
Total Samples
Total Samples

0 Completed out of 0 Expected

GP2 - Fundación Diagnosis

Fundación Diagnosis | Santiago, Chile
Access Data on AMP® PD
Number of Samples Completed and Expected
Case Samples
Case Samples

33 Completed out of 100 Expected
Non-PD Samples
Non-PD Samples

0 Completed out of 0 Expected
Total Samples
Total Samples

33 Completed out of 100 Expected
Ancestry Breakdown for Samples Completed
Show

GP2 - Koc University

Koc University | Istanbul, Turkey
Access Data on AMP® PD
Number of Samples Completed and Expected
Case Samples
Case Samples

80 Completed out of 200 Expected
Non-PD Samples
Non-PD Samples

0 Completed out of 0 Expected
Total Samples
Total Samples

80 Completed out of 200 Expected
Ancestry Breakdown for Samples Completed
Show

GP2 - Koc University M

Koc University | Istanbul, Turkey
Access Data on AMP® PD
Number of Samples Completed and Expected
Case Samples
Case Samples

60 Completed out of 75 Expected
Non-PD Samples
Non-PD Samples

6 Completed out of 0 Expected
Total Samples
Total Samples

66 Completed out of 75 Expected
Ancestry Breakdown for Samples Completed
Show

GP2 - Samsung

Samsung Medical Center | Seoul, South Korea
Number of Samples Completed and Expected
Case Samples
Case Samples

0 Completed out of 500 Expected
Non-PD Samples
Non-PD Samples

0 Completed out of 230 Expected
Total Samples
Total Samples

0 Completed out of 730 Expected

GP2 - Seoul National University Hospital

Seoul National University Hospital | Seoul, South Korea
Access Data on AMP® PD
Number of Samples Completed and Expected
Case Samples
Case Samples

280 Completed out of 280 Expected
Non-PD Samples
Non-PD Samples

1 Completed out of 0 Expected
Total Samples
Total Samples

281 Completed out of 280 Expected
Ancestry Breakdown for Samples Completed
Show

HAWAII PD

The Queen's Medical Center | Honolulu, United States
Number of Samples Completed and Expected
Case Samples
Case Samples

0 Completed out of 100 Expected
Non-PD Samples
Non-PD Samples

0 Completed out of 100 Expected
Total Samples
Total Samples

0 Completed out of 200 Expected

HIPDR

University of Miami | Miami, United States
Number of Samples Completed and Expected
Case Samples
Case Samples

0 Completed out of 140 Expected
Non-PD Samples
Non-PD Samples

0 Completed out of 0 Expected
Total Samples
Total Samples

0 Completed out of 140 Expected

ICEBERG

INSERM, French Institute of Health and Medical Research | Paris, France
Number of Samples Completed and Expected
Case Samples
Case Samples

0 Completed out of 180 Expected
Non-PD Samples
Non-PD Samples

0 Completed out of 70 Expected
Total Samples
Total Samples

0 Completed out of 250 Expected

IGECND

University of Kiel | Kiel, Germany
Access Data on AMP® PD
Number of Samples Completed and Expected
Case Samples
Case Samples

74 Completed out of 1,200 Expected
Non-PD Samples
Non-PD Samples

0 Completed out of 0 Expected
Total Samples
Total Samples

74 Completed out of 1,200 Expected
Ancestry Breakdown for Samples Completed
Show

Demande d’ensemble de données auprès de l’AMP-PD

Une fois que le GP2 a terminé le génotypage d’une cohorte, l’intégralité des données est partagée par le biais de la plateforme sécurisée AMP® PD. Il est obligatoire de s’inscrire pour demander l’accès aux données.

Soumettre une cohorte

Si vous souhaitez collaborer avec l’équipe du GP2, veuillez nous contacter pour soumettre une cohorte ou obtenir de plus amples renseignements sur la procédure à suivre pour devenir membre.

Rencontrez les membres du GP2 du monde entier

Découvrez les membres de notre organisation dont la contribution, notamment en termes d’échantillons et de données, nous permet de poursuivre nos travaux de recherche.